Effects of buspirone in the geller‐seifter conflict test with incremental shock

Drug Development Research

Volumn 19, Issue 1, 1990, Pages 37-49

  Howard, James L ^a   Pollard, Gerald T ^a  

^a Burroughs Wellcome Co   (United States)

Author keywords

animal model; anxiety; anxiolytic; chlordiazepoxide; punishment; rat; response contingent shock

Indexed keywords

BUSPIRONE; CHLORDIAZEPOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONFLICT; ELECTRIC SHOCK; FEMALE; INSTRUMENTAL CONDITIONING; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUNISHMENT; RAT;

EID: 0025166489     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.430190105     Document Type: Article

References (51)

1. A comparison of the anticonflict activity of serotonin agonists and antagonists in rats
2. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms
3. Some putative non‐sedating anxiolytics in a conditioned licking conflict
4. Effect of behaviorally active drugs in a conflict‐punishment procedure in rats
5. Conditonal defensive burying as a model for identifying anxiolytics
6. 1A ligand effects in the X‐maze anxiety test
7. Effects of combined treatment with trifluoroperazine‐HCl and amobarbital on punished behaviour in rats
8. Pharmacological and anatomical analysis of fear conditioning using the fear‐potentiated startle paradigm
9. Serotonin does not mediate anxyiolytic effects of buspirone in the fear‐potentiated startle paradigm: Comparison with 8‐OH‐DPAT and ipsapirone
10. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone
11. Buspirone: Review of its pharmacology and current perspectives on its mechanism of action
12. The neurochemistry of anxiety
13. Models of anxiety
14. Recent developments in 5HT‐related pharmacology of animal models of anxiety
15. Effects of buspirone on operant behavior of laboratory rats and cynomologus monkeys
16. The effects of meprobamate, barbiturates, d‐amphetamine and promazine on experimentally induced conflict in the rat
17. Buspirone: A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic
18. Novel non‐benzodiazepine anxiolytics
19. Pharmacological characterization of a modified social‐interaction model of anxiety in the rat
20. SM‐3997: A non‐benzodiazepine anxiolytic with potent and selective effects on serotonergic neurotransmission
21. 1A receptors have anxiolytic effects when injected into the dorsal raphe nucleus of the rat
22. Effects of ligands for specific 5‐HT receptor sub‐types in two animal tests of anxiety
23. Anxiolytic effects buspirone and gepirone in the fear‐potentiated startle paradigm
24. Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding
25. Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants
26. Buspirone effects in an animal conflict procedure: Comparison with diazepam and pentobarbital
27. The shock probe conflict procedure. A new assay responsive to benzodiazepines, barbiturates and related compounds
28. 1A agonists show an anxiogenic‐like profile in the elevated plus‐maze
29. 3H]flunitrazepam binding in vivo
30. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: Are exploratory models of anxiety in rodents valid?
31. Validation of open:closed arm entries in an elevated plus‐maze as a measure of anxiety in the rat
32. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus‐maze: A novel test of anxiety in the rat
33. Selective agonists and antagonists for 5‐hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plusnmaze test in the rat
34. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: Possible role of dopamine
35. The Geller‐Seifter conflict paradigm with incremental shock
36. Pharmacology and neurochemistry of buspirone
37. Behavioral effects of nonbenzodiazepine anxiolytic drugs: A comparison of CGS 9896 and zopiclone with chlordiazepoxide
38. The face to face test for anxiolytics: A social interaction test in mice
39. Pharmacological properties of SM‐3997. A new anxioselective anxiolytic candidate
40. A preclinical evaluation of buspirone in neuropharmacologic, EEG, and anticonflict test procedures
41. Pharmacological and clinical effects of buspirone
42. Animal models for the study of anti‐anxiety agents: A review
43. A comparison of buspirone and chlordiazepoxide in the shock‐probe/burying test for anxiolytics
44. Comparison between chronic chlordiazepoxide treatment and shock removal in a conflict situation in rats
45. A simple and reliable conflict procedure for testing anti‐anxiety agents
46. Behavioral and neurochemical studies on the anticonflict action of buspirone
47. Behavioral effects of acute and chronic buspirone
48. Interaction of buspirone and dopaminergic agents on punished behavior of pigeons
49. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons
50. Behavioral effects of several new anxiolytics and pututive anxiolytics